There are three general categories of drugs that are commonly used topreventor treatblood clots(thrombosis): anticoagulants, fibrinolytics, and antiplatelet medications. Some of these (Pradaxa, Angiomax, ReoPro) may be unfamiliar, while others (warfarin, heparin, aspirin) are generally household names...
If a history of prior spontaneous abortion or thrombosis is present, the patient is placed on low molecular weight heparin. In patients with ITP, we consider safe for anticoagulation a platelet count stably > 50 × 109/L. How should delivery be managed? What is a safe platelet count for ...
though its elevation has not been reported in numerous RCTs [139]. Uncontrolled observational studies indeed have demonstrated a twofold–threefold increase in the occurrence rate of thrombotic events in TPO-RA-treated patients [140]; thus, extra attention is needed, especially in patients at a...
Rituximab is a chimeric monoclonal antibody targeting CD20-expressing B cells. It has been commonly used as an off-label treatment for ITP for nearly 2 decades. The short-term response rates range from 60 to 70% in patients treated with the standard 4 weekly doses of 375 mg/m2 rituximab,...
Myelosuppressive drugs can reduce the rate of thrombosis, but there is concern that their use raises the risk of transformation into acute leukemia. To tackle this dilemma, a risk-oriented management strategy is recommended. Low-risk patients should be treated with phlebotomy and low-dose aspirin....
Merli GJ. Deep-vein thrombosis in malignancy: how long should patients be treated, and with what?[J].Catheterization and cardiovascular interventions 2009,Suppl.1(Suppl.1).Merli GJ. Deep-vein thrombosis in malignancy: how long should patients be treated, and with what? Catheter Cardiovasc Interv...
A 32-year-old G1P0 Ghanaian woman with HbSS is 10 weeks pregnant. She developed a left femoral vein deep venous thrombosis at age 26 years during a hospitalization for VOC, and was treated with low-molecular-weight heparin (LMWH) followed by warfarin for 6 months. She has not had recurrent...
- 《Thrombosis & Haemostasis》 被引量: 120发表: 2013年 New Oral Anticoagulants: A Review of the Literature with Particular Emphasis on Patients with Impaired Renal Function. Oral anticoagulant therapy (OAT) is widely used to prevent and treat thromboembolic events. Traditionally, warfarin has been ...
How is venous thrombosis different from arterial thrombosis? How does myocardial ischemia lead to myocardial infarction? How long does ischemic heart disease take to develop? Is ischemic heart disease curable? Is CHD and stable ischemic heart disease the same thing?
AVWS is ch... R Montogomery - 《Haemostasis & Thrombosis Basic Principles & Clinical Practice》 被引量: 67发表: 0年 How I treat type 2B von Willebrand disease Type 2B von Willebrand disease (VWD) is an inherited bleeding disorder caused by changes in von Willebrand factor (VWF) that ...